Older adults diagnosed with autism face a significantly higher risk of developing Parkinson’s disease-related movement ...
Owen’s family watched him change from a happy and energetic child to one who was often moody and unhappy. His parents were told he had autism, but they sensed something was missing in ...
The brain-gut axis is being studied for its potential role in autism-related communication difficulties, although evidence ...
A registered randomized controlled trial protocol outlines a 12-week interactive exercise intervention for children with ...
A four-year old US boy’s life – and that of his family – has been completely transformed since he started treatment on a “miracle drug” for his severe autism four months ago, reports New York Post.
People with autism report more severe menopause symptoms, higher anxiety, and poorer quality of life, highlighting a need for ...
The Melbourne company dosed the first patient in its Beyond Harmony study of NTI164 on 21 September. All six sites across ...
L1-79 is an oral drug developed by Yamo Pharmaceuticals to target autism’s core symptoms. About 116 patients have reportedly ...
A particular signaling protein in the brain could be a therapeutic target for neurological disorders arising from the ...
Idorsia Ltd. is branching into a new indication for its dual orexin 1 and 2 antagonist drug Quviviq (daridorexant), after a phase II pediatric insomnia trial showed unexpected improvements in the ...
An experimental comparison of 17 autism-risk mouse lines identified two opposing brain-gene activity states that varied with ...
An oral drug designed to treat the core symptoms of autism spectrum disorder, has been dubbed by some as 'the Ozempic of ...